Skip to content
Cart

#91 - Rethinking TRT: What Testosterone Therapy Really Achieves | Dr. Eveline Urselmann on Men's Health

Testosterone deficiency, TRT & longevity—but done right: In this episode, Dr. Jonathan Apasu talks with Dr. Eveline Urselmann about the reality of testosterone replacement therapy. What does the diagnostic process really look like? Which blood values are crucial, and why are reference ranges often misleading? Eveline explains why therapy is a process (feedback, monitoring, adjustments), which delivery methods she prefers, and how to recognize an overdose early on—often through psychological changes and first in one's social circle.

Also: Why supplements rarely "save" testosterone, which longevity building blocks they still optimize (vitamin D, omega-3, trace elements, cardiovascular markers), and when statins may even be relevant temporarily. Finally, things get controversial: growth hormone in the longevity approach. Target values similar to those of a 28–35-year-old, potential benefits, open questions about risks, and why it is so expensive.

Topics in this episode:

  • Diagnostics: medical history, questionnaire, blood draw, and "optimal ranges" vs. reference ranges
  • TRT in practice: IM injection vs. gel (compounding) and what works for whom
  • Why patients often do not notice an overdose themselves (psychology, behavior, social circle)
  • Hematocrit/hemoglobin: the safety checkpoint in TRT
  • Supplements and longevity: What really helps and what is wishful thinking?
  • Growth hormone: use, target values, benefits, risks, and costs

If you want to not only "do" TRT but also understand it, tune in!